DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells
出版年份 2016 全文链接
标题
DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells
作者
关键词
-
出版物
LEUKEMIA
Volume 31, Issue 3, Pages 688-696
出版商
Springer Nature
发表日期
2016-10-17
DOI
10.1038/leu.2016.284
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Approaches of targeting Rho GTPases in cancer drug discovery
- (2015) Yuan Lin et al. Expert Opinion on Drug Discovery
- Rac1 GTPase-deficient HeLa cells present reduced DNA repair, proliferation, and survival under UV or gamma irradiation
- (2015) Gisele Espinha et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
- (2015) Kerry Dobbs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
- (2015) Yiting Lim et al. Science Translational Medicine
- Dock-family exchange factors in cell migration and disease
- (2014) Gilles Gadea et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
- (2014) Jun Yu et al. GUT
- DOCK2 and DOCK5 Act Additively in Neutrophils To Regulate Chemotaxis, Superoxide Production, and Extracellular Trap Formation
- (2014) Mayuki Watanabe et al. JOURNAL OF IMMUNOLOGY
- DOCK2 Is Critical for CD8+TCR−Graft Facilitating Cells to Enhance Engraftment of Hematopoietic Stem and Progenitor Cells
- (2014) Yujie Wen et al. STEM CELLS
- Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
- (2014) Anindya Chatterjee et al. Cell Reports
- Immune regulatory functions of DOCK family proteins in health and disease
- (2013) Akihiko Nishikimi et al. EXPERIMENTAL CELL RESEARCH
- Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2
- (2013) K. Yasuda et al. INTERNATIONAL IMMUNOLOGY
- RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
- (2013) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
- (2013) Austin M Dulak et al. NATURE GENETICS
- Blockade of Inflammatory Responses by a Small-Molecule Inhibitor of the Rac Activator DOCK2
- (2012) Akihiko Nishikimi et al. CHEMISTRY & BIOLOGY
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- Further activation of FLT3 mutants by FLT3 ligand
- (2011) R Zheng et al. ONCOGENE
- DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma
- (2010) Lei Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Dock2 participates in bone marrow lympho-hematopoiesis
- (2008) Tomoko Kikuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
- (2008) A. Sallmyr et al. BLOOD
- Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac
- (2008) Balakrishnan Selvakumar et al. FEBS LETTERS
- Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia
- (2008) Weiguo Zhang et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now